Patents Examined by Ali Soroush
  • Patent number: 10183001
    Abstract: An abuse deterrent drug product is provided wherein the drug product comprises a matrix and a drug substance in the matrix wherein the drug substance is defined as a 1:1 salt of a pharmaceutically active compound and BNDO.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: January 22, 2019
    Assignee: Pisgah Laboratories, Inc.
    Inventors: Clifford Riley King, Stephen G. D'Ambrosio, David W. Bristol
  • Patent number: 10149853
    Abstract: Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: December 11, 2018
    Assignee: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Rong-Kun Chang, Michael L. Vieira, Likan Liang, Padmanabh P. Bhatt, Austin B. Huang, Sachin V. Patel
  • Patent number: 10123532
    Abstract: Embodiments of the present invention disclose using low hydrophilic-lipophilic balance surfactants as spray drift reduction agents and methods of using such agents.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: November 13, 2018
    Assignee: HUNTSMAN PETROCHEMICAL LLC
    Inventor: Curtis M. Elsik
  • Patent number: 10058570
    Abstract: The present invention relates to the use of arsenic compounds such as sodium meta arsenite (NaAsO2), arsenic trioxide (As2O3), and arsenic hexoxide (As4O6) or combinations thereof, for the treatment of painful, hyperalgesic and/or inflammatory conditions. The present invention also relates to compositions containing the above arsenic compounds for use in the treatment of pain, inflammation and immunological and autoimmune diseases and disorders.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: August 28, 2018
    Assignee: Panaphix Inc.
    Inventors: Michael Hwang, Yong Jin Yang
  • Patent number: 10045944
    Abstract: The present invention provides a pharmaceutical formulation comprising clomipramine or its pharmaceutically acceptable salt (preferably, clomipramine hydrochloride) as the first active ingredient, and sildenafil or its pharmaceutically acceptable salt (preferably, sildenafil citrate) as the second active ingredient, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation. In particular, the present invention provides a pharmaceutical formulation comprising the above two active ingredients and manufactured by using a wet granulation method, wherein stability of clomipramine is improved, and a method for manufacturing this pharmaceutical formulation.
    Type: Grant
    Filed: December 29, 2014
    Date of Patent: August 14, 2018
    Assignee: CTC BIO, INC.
    Inventors: Hong Ryeol Jeon, Bong-Sang Lee, Seong-Shin Kwak, Dong-Jin Lee, Hyun-Jung Park, Jung-Hwa Kim
  • Patent number: 10028991
    Abstract: The present invention relates to a composition, and methods of using the composition, for minimizing the harmful effects associated with alcohol consumption. The composition includes a plurality of ingredients, which when combined, have the unexpected effect of increasing one or more metabolic pathways in the individual. As the metabolic rate is increased, alcohol is burned off, or utilized as energy source, and occurs at a considerably much faster rate than under normal physiological means. It is believed that the composition may have an effect on the brain causing it to increase metabolic rates. By administering the composition to an inebriated individual, the rate at which a person sobers up, occurs at a faster rate than would occur under normal physiological time frames.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: July 24, 2018
    Assignee: GDB Patent Holdings, LLC
    Inventor: Gregory Blackman
  • Patent number: 10011486
    Abstract: Methods for the synthesis of tricalcium phosphates are presented, as well as a series of specific reaction parameters that can be adjusted to tailor, in specific ways, properties in the tricalcium phosphate precursor precipitate. Particulate tricalcium phosphate compositions having an average crystal size of about 250 nm or less are provided. Compositions of the invention can be used as prosthetic implants and coatings for prosthetic implants.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: July 3, 2018
    Assignee: Pioneer Surgical Technology, Inc.
    Inventor: Edward S. Ahn
  • Patent number: 9993431
    Abstract: The invention relates to the use of an oral dosage form based on microgranules and/or microtablets to reduce the abusive use of at least one active principle contained therein. The aim of the invention is to prevent the diversion of an oral dosage form based on microgranules and/or microtablets containing at least one active principle capable of causing a dependency, a gelling agent, and a gelling activator. The gelling agent and the activator are only brought into contact with each other in the event of diversion by crushing. Said judiciously selected pair of excipients confers a viscosity to the formulation, such that said formulation cannot be administered by injection or does not release the active principle rapidly by forming a gel when it comes into contact with the mucous membrane if nasally administered.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: June 12, 2018
    Assignee: Ethypharm
    Inventor: Vincent Billoet
  • Patent number: 9968097
    Abstract: The present invention relates to a composition comprising at least one biological control agent. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.
    Type: Grant
    Filed: May 29, 2013
    Date of Patent: May 15, 2018
    Assignee: Bayer CropScience AG
    Inventors: Ulrike Wachendorff-Neumann, Wolfram Andersch, Klaus Stenzel, Bernd Springer
  • Patent number: 9936704
    Abstract: Gelatinous materials combined with the Colloidal Silver additive to formulate an antimicrobial product having cushioning properties. Embodiments of the present invention can include gelatinous materials selected from a group consisting of thermosetting polymer, Styrene-Ethylene-Butadiene-Styrene polymer (SEBS), Thermoplastic Elastomer (TPE), and Polyurethane (PU) gelatin with and without a raised geometry on an outer surface.
    Type: Grant
    Filed: December 29, 2014
    Date of Patent: April 10, 2018
    Inventor: Thomas P. Davis
  • Patent number: 9931318
    Abstract: The present invention provides methods of improving cognitive and motor deficits associated with central nervous system (CNS) disorder or condition in an animal. The methods comprise a general administration of phosphodiesterase 4 inhibitors and optionally training the animal under conditions sufficient to produce an improvement in performance.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: April 3, 2018
    Assignee: DART NEUROSCIENCE (CAYMAN) LTD.
    Inventors: Thomas M. Hallam, Tim Tully, Rusiko Bourtchouladze
  • Patent number: 9925206
    Abstract: Compositions and methods of utilizing the same are provided for treating bacterial infections. The compositions comprise acidified nitrite in combination with an iron chelator and an antibiotic. The compositions of the present invention are effective at treating bacterial infections with minimal to no side effects. Surprisingly, the combination of these three agents has a synergistic effect, which advantageously permits a lower dose of one or more of the active agents (e.g., the antibiotic).
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: March 27, 2018
    Assignee: UNIVERSITY OF CINCINNATI
    Inventor: Daniel J. Hassett
  • Patent number: 9919016
    Abstract: The present disclosure describes chemopreventative and/or chemotherapeutic compositions for inducing apoptosis in cancer cells which include kale and methods of inducing apoptosis in cancer cells utilizing the chemopreventative and/or chemotherapeutic compositions including kale.
    Type: Grant
    Filed: February 10, 2016
    Date of Patent: March 20, 2018
    Inventors: Bilal Qizilbash, Elizabeth Brandon
  • Patent number: 9913790
    Abstract: The invention relates to a water-in-oil antiperspirant composition comprising: A) an aqueous phase containing dissolved antiperspirant active; B) an oil phase comprising: i) an amido gelator; ii) a fatty alcohol that is liquid at 25° C.; iii) a primary non-volatile emollient oil having a refractive index of from 1.47 to 1.56; iv) a secondary non-volatile emollient oil having a refractive index of from 1.38 to 1.451 and C) and emulsifier; and further to a method of production of said antiperspirant composition.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: March 13, 2018
    Assignee: Conopco, Inc.
    Inventors: Martin Peter Cropper, Kevin Ronald Franklin
  • Patent number: 9907312
    Abstract: The present invention relates to a composition comprising at least one biological control agent. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.
    Type: Grant
    Filed: May 29, 2013
    Date of Patent: March 6, 2018
    Assignee: Bayer CropScience AG
    Inventors: Elke Hellwege, Wolfram Andersch, Klaus Stenzel, Bernd Springer
  • Patent number: 9883995
    Abstract: Disclosed are oral care compositions, for example dentifrice compositions, comprising an oral care composition comprising an orally acceptable vehicle, metal oxide particles having an average particle size of no greater than a dentin tubule and at least one amino acid capable of chelating the metal oxide. The composition may comprise a polymeric adherent material for adhering the metal oxide particles in the dentin tubule. The metal oxide particles have a median particle size of 5 microns or less, and may comprise zinc oxide.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: February 6, 2018
    Assignee: Colgate-Palmolive Company
    Inventors: Michael Prencipe, Andre Morgan, Venda Porter Maloney
  • Patent number: 9861725
    Abstract: A multilayer protein film has a mass of greater than 0.5 ?g/cm2 and consists essentially of protein. A drug delivery device comprises the multilayer protein film onto which a pharmaceutically active agent can be loaded. A biomedical implant comprises an implant substrate and the multilayer protein film on at least a portion of the implant substrate surface. A method of making a multilayer protein film having a mass of greater than 0.5 ?g/cm2 comprises contacting a substrate with a protein solution at a temperature of from about 30° C. to about 95° C, wherein a multilayer protein film having a mass of greater than 0.5 ?g/cm2 is formed on the substrate.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: January 9, 2018
    Assignee: ADDBIO AB
    Inventors: Ella Cathrine Vikinge, Elin Engström, Henrik Aronsson, Oskar Axelsson
  • Patent number: 9854795
    Abstract: The present disclosure relates generally to the field of agricultural chemicals and, more particularly, to compositions which can be added to agricultural chemicals for the purpose of improving efficacy and reducing drift of sprayed chemicals away from target areas. Further disclosed are processes for preparing combination water conditioning adjuvant and drift reduction compositions as well as methods of drift reduction utilizing such compositions.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: January 2, 2018
    Assignee: AGQUAM LLC
    Inventor: Scott Parrish
  • Patent number: 9839631
    Abstract: A method for inhibiting hatching of an ectoparasite egg, the method comprising exposing the ectoparasite egg to at least one metal chelating agent and/or metalloprotease inhibitor, wherein the metal chelating agent is a compound comprising at least two heteroatoms able to simultaneously coordinate with a metal ion, at least one of the two heteroatoms being selected from nitrogen, sulfur, oxygen and phosphorus, wherein the compound comprises at least one carbocyclic ring substituted with at least one heteroatom and/or with a substituent containing at least one heteroatom, or the compound comprises at least one heterocyclic ring containing at least one heteroatom, wherein said heterocyclic ring is optionally substituted with at least one heteroatom and/or with a substituent containing at least one heteroatom is provided. Methods of treating ectoparasite infestations and compositions for use in such methods are also provided.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: December 12, 2017
    Assignee: DR. REDDY'S LABORATORIES, S.A.
    Inventor: Vernon Morrison Bowles
  • Patent number: 9833536
    Abstract: A contact lens storage system that includes sterilized solution, at least one contract lens, a buffering agent, and a container. The sterilized solution and contact lens are physically separated from the buffering agent. Also described herein are related methods for neutralizing a sterilized contact lens solution, methods of inserting a contact lens onto an eye, and methods of disinfecting and neutralizing a contact lens.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: December 5, 2017
    Assignee: Medivators Inc.
    Inventors: John J. Matta, Jon Olson, Matt Conlon